Table 2 Fluorescence Lifetime measurements of our human samples series.
Lifetime values (ns) | Glioma Group | Metastasis Group | Control Group | Meningioma Group | Meningioma control Group |
|---|---|---|---|---|---|
(n = 16) | (n = 14) | (n = 11) | (n = 8) | (n = 5) | |
Parameter | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
λ exc = 375 nm | |||||
NADH | 4.01 (1.29) | 4.05 (1.02) | 3.41 (0.80) | 3.94 (0.58) | 5.30 (0.30) |
FAD | 3.88 (1.18) | 4.29 (0.81) | 3.87 (0.56) | 3.90 (0.69) | 5.22 (0.27) |
λ exc = 405 nm | |||||
NADH | 2.55 (0.61) | 2.71 (0.51) | 3.38 (0.62) | 3.22 (0.73) | 4.58 (0.98) |
FAD | 2.71 (0.64) | 2.71 (0.53) | 3.29 (0.55) | 3.27 (0.67) | 4.83 (0.87) |
Lipopigment | 3.80 (1.18) | 3.66 (0.80) | 5.21 (2.72) | 3.86 (0.88) | 9.58 (5.16) |
Porphyrin I | 2.57 (0.88) | 3.00 (1.17) | 2.92 (1.12) | 2.60 (0.46) | 4.00 (0.88) |
Porphyrin II | 2.41 (1.19) | 2.53 (1.16) | 2.96 (0.92) | 1.91 (0.36) | 3.25 (0.77) |
